You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

High risk hematologic malignancies

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hematologic Tumors Trial run by the NCI (donor lymphocyte infusion, Cyclophosphamide, Busulfan)

Suspended
  • Hematologic Neoplasms
  • donor lymphocyte infusion
  • +5 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Nov 30, 2022

MDS, de Novo, MDS, Secondary, MDS, Previously Treated Trial in Boston (Venetoclax, Azacitidine, Cytarabine)

Recruiting
  • Myelodysplastic Syndromes, de Novo
  • +10 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Jan 23, 2023

Relapsed and/or Refractory Acute Myeloid Leukemia, High Risk Hematologic Malignancies Trial in Langfang (anti-CD33 CAR T cells)

Not yet recruiting
  • Relapsed and/or Refractory Acute Myeloid Leukemia
  • High Risk Hematologic Malignancies
  • anti-CD33 CAR T cells
  • Langfang, Hebei, China
    Hebei Yanda Lu Daopei Hospital
Jun 30, 2022

Relapsed/Refractory, High Risk Hematologic Malignancies, T-ALL/Lymphoma Trial in Langfang (CD7CAR T cells)

Recruiting
  • Relapsed/Refractory, High Risk Hematologic Malignancies
  • T-ALL/Lymphoma
  • CD7CAR T cells
  • Langfang, Hebei, China
    Hebei Yanda Lu Daopei Hospital
Jun 30, 2022

Hematologic Malignancies, Relapse, GVHD Trial in Ann Arbor (Carfilzomib, Tacrolimus)

Completed
Has Results
  • Hematologic Malignancies
  • +2 more
  • Ann Arbor, Michigan
    University of Michigan Hospital
Dec 3, 2021

Acute Myeloid Leukemia, B-cell Acute Lymphoblastic Leukemia, High-risk Myelodysplastic Syndrome Trial (VIP943)

Not yet recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • (no location specified)
Sep 5, 2023

Hematologic Tumors Trial in Milan (Cyclophosphamide, Hematopoietic Stem Cell Transplantation,)

Recruiting
  • Hematologic Neoplasms
  • Milan, Italy
    European Institute of Oncology
Sep 24, 2021

Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With

Active, not recruiting
  • Adult Acute Lymphoblastic Leukemia in Remission
  • +14 more
  • radiation therapy
  • +8 more
  • Columbus, Ohio
    Arthur G. James Cancer Hospital and Solove Research Institute at
Oct 7, 2022

Hematologic Malignancy, Acute Myeloid Leukemia, MDS Trial in Chengdu, Shenzhen (CLL1-CD33 cCAR T cells)

Recruiting
  • Hematologic Malignancy
  • +4 more
  • CLL1-CD33 cCAR T cells
  • Chengdu, China
  • +1 more
May 17, 2021

Acute Myelogenous Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Chronic Myelogenous Leukemia (CML) Trial in United States

Recruiting
  • Acute Myelogenous Leukemia (AML)
  • +5 more
  • Conditioning Chemotherapy
  • Cord blood graft
  • Basking Ridge, New Jersey
  • +6 more
May 22, 2023

Acute Leukemia of Ambiguous Lineage, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Seattle (procedure, drug,

Not yet recruiting
  • Acute Leukemia of Ambiguous Lineage
  • +8 more
  • Biospecimen Collection
  • +12 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Aug 22, 2023

Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Hodgkin Lymphoma Trial in Madison (TCRaß+/CD19+ depleted Haploidentical

Recruiting
  • Acute Myeloid Leukemia
  • +10 more
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
Mar 1, 2022

Leukemia, Myelodysplastic Syndrome, Lymphoma Trial in New York (CliniMACS Fractionation system (Arm A), CliniMACS Fractionation

Completed
Has Results
  • Leukemia
  • +2 more
  • CliniMACS Fractionation system (Arm A)
  • +2 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jul 12, 2022

Acute Leukemia, Chronic Leukemia, Myelodysplastic Syndrome Trial in Atlanta (MLN9708)

Completed
Has Results
  • Acute Leukemia
  • +4 more
  • Atlanta, Georgia
    Northside Hospital
Sep 1, 2021

Acute Myeloid Leukemia, Acute Lymphoid Leukemia, Mixed Phenotype Acute Leukemia Trial in United States (Orca-T,

Recruiting
  • Acute Myeloid Leukemia
  • +7 more
  • Orca-T
  • Standard-of-Care
  • Duarte, California
  • +13 more
Jan 25, 2023

Myeloproliferative Disorders, Acute Myelogenous Leukemia, Chronic Myelogenous Leukemia Trial run by the NHLBI (T-cell replete

Completed
Has Results
  • Myeloproliferative Disorders
  • +4 more
  • T-cell replete PBPC allograft
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Oct 12, 2022

High Risk Hematologic Malignancies Trial in Salt Lake City (stem cell transplant, Stem cell transplant)

Terminated
  • High Risk Hematologic Malignancies
  • stem cell transplant
  • Stem cell transplant
  • Salt Lake City, Utah
    Huntsman Cancer Institute
Aug 10, 2020

Acute Myeloid Leukemia Trial in Japan (PF-04449913, Low dose ARA-C (LDAC), Daunorubicin)

Active, not recruiting
Has Results
  • Acute Myeloid Leukemia
  • Nagoya, Aichi, Japan
  • +8 more
Jan 12, 2022

Relapsed/Refractory Hematopoietic Malignancies, Acute Myeloid Leukemia and MDS Trial in Washington, Baltimore (Tumor associated

Recruiting
  • Relapsed/Refractory Hematopoietic Malignancies, Acute Myeloid Leukemia and MDS
  • Tumor associated antigen lymphocytes (TAA-T)
  • Washington, District of Columbia
  • +1 more
Jul 15, 2021

Hematologic Malignancies, Inborn Errors of Metabolism Disorders, Immune Deficiencies Trial in Durham (CliniMACS CD34 Reagent

Available
  • Hematologic Malignancies
  • +2 more
  • CliniMACS CD34 Reagent System
  • Durham, North Carolina
    Duke University Medical Center
Nov 12, 2021

Allogeneic Hematopoietic Stem Cell Transplantation, Allogeneic Stem Cell Transplantation, Hematologic Malignancies Trial in

Not yet recruiting
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +2 more
  • Orange, California
    Chao Family Comprehensive Cancer Center, University of Californi
Aug 31, 2023

Acute Leukemia, Multiple Myeloma, Non-Hodgkin Lymphoma Trial (3D189)

Recruiting
  • Acute Leukemia
  • +3 more
  • 3D189
  • Guangzhou, Guangdong, China
  • +3 more
Jan 2, 2023

Hematological Malignancies Trial in Bologna (Intrabone cord blood infusion)

Completed
  • Hematological Malignancies
  • Intrabone cord blood infusion
  • Bologna, Italy
    Hematology Institute "L. and A. Seràgnoli", S. Orsola-Malpighi U
Mar 18, 2021

Hematologic Malignancies Trial in Houston (BPX-501, AP1903)

Withdrawn
  • Hematologic Malignancies
  • Houston, Texas
    MD Anderson Cancer Center
Oct 1, 2020

Leukemia, MDS, Lymphomas Trial (rivogenlecleucel, Rimiducid)

Withdrawn
  • Leukemia
  • +4 more
  • (no location specified)
Oct 1, 2020